Melasma on Asian skin (Fitzpatrick III–V) is harder to treat than on lighter skin — higher PIH risk, more complex pigment depth, tighter protocol margins. Single-modality approaches underperform. Here's the comprehensive multi-modality framework JRYN uses.
Asian melasma is multi-modality. PicoPlus alone is not enough.
Melasma on Asian skin requires more than any single laser device. JRYN's standard Asian melasma protocol combines 4–6 modalities: (1) PicoPlus laser(multi-wavelength pico for pigment fragmentation), (2) oral tranexamic acid 250mg twice daily (off-label, with screening), (3) topical compound(hydroquinone-tranexamic-vitamin C), (4) strict SPF 50+ daily(lifelong), (5) periodic exosome therapy for healing support, (6) optional HIFU or microneedling for textural concerns. Realistic outcome: 60–80% improvement over 4–6 months, sustained with lifelong maintenance. Lighter Fitzpatrick III responds better than darker V. Fitzpatrick VI patients require very conservative protocols. Total protocol cost runs $1,200–$2,800 depending on session count and modalities. Be skeptical of any clinic promising single-laser solution — Asian melasma needs the full system.
Multi-wavelength picosecond pulses fragment pigment without thermal damage. 5–8 sessions spaced 3–4 weeks. Conservative-first approach: lower energy session 1, gradual build. Asian skin protocol calibration essential — this is not the place to maximize energy.
Off-label use at 250mg twice daily for 3–6 months. Reduces melanocyte activity. Strong clinical evidence for Asian melasma. Requires screening for clot risk (smoking, hormonal contraceptives, thrombophilia, recent surgery). JRYN consults appropriate physician for clearance.
Hydroquinone 4% + tranexamic acid 5% + vitamin C 10% compound between sessions. Daily use, evening application. JRYN-formulated by partner pharmacy. Cycling on/off (3 months on, 1 month off) prevents tolerance. Skipping topicals undermines laser results.
Mineral SPF 50+ minimum, applied morning + reapplication every 2 hours outdoors. Wide-brimmed hat outdoors. Sun avoidance during peak hours (10am–4pm). This is non-negotiable. Skipping sun protection is the #1 cause of treatment failure.
Optional adjunct between PicoPlus sessions to support healing and reduce PIH risk. 2–3 sessions during the laser series. Particularly valuable for Fitzpatrick IV–V where PIH risk is higher. Adds cost but improves outcome.
After 4–6 month series: quarterly or semi-annual touch-up PicoPlus session. Continuous topicals (lower-strength maintenance compound). Continuous SPF. Periodic oral TXA cycles for high-recurrence patients. Lifelong system, not one-time fix.
Best response to standard protocol. 70–85% improvement realistic. Lower PIH risk. Standard energy parameters and session count typically sufficient.
Most common JRYN patient profile. 60–75% improvement realistic. Moderate PIH risk requires conservative escalation. Standard 5–8 session series.
Higher PIH risk requires more conservative protocol. Lower energy, longer spacing (4–5 weeks). Exosome adjunct strongly recommended. 50–70% improvement realistic.
Carefully calibrated protocol essential. Very conservative energy escalation. Topicals carry more weight. 40–60% improvement realistic with extended timeline (8+ months).
Highest PIH risk. JRYN treats with extreme caution — sometimes refers to specialty pigmentation clinics. Topical-dominant protocol with minimal laser. 30–50% improvement realistic.
Often improves spontaneously postpartum. Defer all treatment during pregnancy and breastfeeding. Wait 6 months postpartum, evaluate residual. Treat as standard protocol if persistent.
JRYN's primary melasma laser. 1064nm + 532nm picosecond pulses. KFDA-approved. Authentic Lutronic-supplied unit with manufacturer service contract.
Custom-formulated hydroquinone-tranexamic acid-vitamin C compound. Pharmaceutical-grade. JRYN partners with licensed compounding pharmacy. Stronger and better-tolerated than over-the-counter alternatives.
Standard 500mg tablets, prescribed at 250mg twice daily for melasma indication. Generic available; JRYN works with partner physicians for screening and prescription. Off-label but well-studied for melasma.
Stem cell-derived exosomes from KFDA-approved sources. Applied topically post-laser or post-microneedling. Accelerates healing and reduces PIH formation in Asian skin.
Morning: gentle cleanser → vitamin C → niacinamide → SPF 50+. Evening: gentle cleanser → tranexamic acid topical → moisturizer. Weekly: skip actives one night for skin recovery. This is non-negotiable lifelong, not optional.
Wide-brimmed hat outdoors. Avoid peak hours (10am–4pm) when possible. SPF reapplication every 2 hours outdoors. Indoor near-window UV exposure also matters — UV passes through window glass. Some patients add UV-protective window film.
Single PicoPlus maintenance session every 3–6 months. Continues to push pigment back. Skipping touch-ups for 6+ months causes detectable regression. Plan trip schedule to align with touch-up timing.
Topical hydroquinone: 3 months on, 1 month off pattern prevents tolerance. Oral tranexamic acid: 3–6 month cycles with breaks. Vitamin C and SPF: continuous, no breaks. JRYN provides written schedule to follow.
Dr. Lee Portrait
A medical decision should not feel rushed.
My job is to give you the 30 minutes you couldn't get at home
—
then deliver treatment that respects what made you fly here in the first place.
WhatsApp us photos showing your melasma. Within 24 hours we share Fitzpatrick assessment, recommended modality combination, realistic outcome expectation, and total protocol pricing. We tell you the truth about lifelong management.
Individual results may vary. Content is for informational purposes only and is not a substitute for medical advice. Please consult a licensed medical professional before any procedure. Prices are estimates and may change. JRYN Dermatology is licensed under the Korean Medical Service Act.
Contact number : +82-10-3951-7576
Address:
4F, Samjeong Tower, 672 Jungang-daero, Busanjin-gu, Busan, Korea